肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 BGCS指南：宫颈癌

2020-09-29 Eur J Obstet Gynecol Reprod Biol . 2020 Sep 29;

宫颈癌

2020年9月，英国妇科肿瘤学会(BGCS)发布了宫颈癌管理指南。在许多国家，由于筛查计划和疫苗接种计划，宫颈癌在未来几十年里的发病率将会降低。本文主要针对宫颈癌的管理提出指导建议。

中文标题：

2020 BGCS指南：宫颈癌

英文标题：

British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: Recommendations for practice

发布机构：

发布日期：

2020-09-29

简要介绍：

2020年9月，英国妇科肿瘤学会(BGCS)发布了宫颈癌管理指南。在许多国家，由于筛查计划和疫苗接种计划，宫颈癌在未来几十年里的发病率将会降低。本文主要针对宫颈癌的管理提出指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 BGCS指南：宫颈癌.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a92ee1c00200e221, title=2020 BGCS指南：宫颈癌, enTitle=British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: Recommendations for practice, guiderFrom=Eur J Obstet Gynecol Reprod Biol . 2020 Sep 29;, authorId=0, author=, summary=2020年9月，英国妇科肿瘤学会(BGCS)发布了宫颈癌管理指南。在许多国家，由于筛查计划和疫苗接种计划，宫颈癌在未来几十年里的发病率将会降低。本文主要针对宫颈癌的管理提出指导建议。, cover=https://img.medsci.cn/20201110/1605020504570_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Sep 29 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年9月，英国妇科肿瘤学会(BGCS)发布了宫颈癌管理指南。在许多国家，由于筛查计划和疫苗接种计划，宫颈癌在未来几十年里的发病率将会降低。本文主要针对宫颈癌的管理提出指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=1402, tagName=宫颈癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1402, guiderKeyword=宫颈癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7531, appHits=707, showAppHits=0, pcHits=1218, showPcHits=6824, likes=8, shares=30, comments=44, approvalStatus=1, publishedTime=Tue Nov 10 23:11:31 CST 2020, publishedTimeString=2020-09-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 10 23:03:21 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:10:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 BGCS指南：宫颈癌.pdf)])
2020 BGCS指南：宫颈癌.pdf
下载请点击：
评论区 (34)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1186009, encodeId=c1ce1186009c2, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/tFIbqG99ULWomyW3q9TDNWhssrBa1C42kwt9ViaYyFDEZaPsW5uSkpdc5yQ7P9X63kiaRQzMr6durvzUyNNNULBw/132, createdBy=396a2268565, createdName=yumeng0126, createdTime=Wed Jan 19 14:03:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082310, encodeId=f988108231052, content=好文章，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf915716762, createdName=ms4000001060959647, createdTime=Tue Dec 21 06:55:17 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998739, encodeId=a7cc998e393d, content=学习，有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:04:49 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970353, encodeId=b3c89e035343, content=学习，好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOE7FCnhQj6vMstukoEoP7anFuTKzdMKnbTfCYicnCjiboPUiaSFo4oOsupAWuaibPWgSFribubP16FHA/132, createdBy=11935284296, createdName=visa, createdTime=Wed Jun 02 15:36:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968219, encodeId=4e30968219d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1bb2136466, createdName=ooo0830, createdTime=Mon May 24 20:09:07 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2022-01-19 yumeng0126

    棒棒哒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1186009, encodeId=c1ce1186009c2, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/tFIbqG99ULWomyW3q9TDNWhssrBa1C42kwt9ViaYyFDEZaPsW5uSkpdc5yQ7P9X63kiaRQzMr6durvzUyNNNULBw/132, createdBy=396a2268565, createdName=yumeng0126, createdTime=Wed Jan 19 14:03:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082310, encodeId=f988108231052, content=好文章，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf915716762, createdName=ms4000001060959647, createdTime=Tue Dec 21 06:55:17 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998739, encodeId=a7cc998e393d, content=学习，有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:04:49 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970353, encodeId=b3c89e035343, content=学习，好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOE7FCnhQj6vMstukoEoP7anFuTKzdMKnbTfCYicnCjiboPUiaSFo4oOsupAWuaibPWgSFribubP16FHA/132, createdBy=11935284296, createdName=visa, createdTime=Wed Jun 02 15:36:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968219, encodeId=4e30968219d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1bb2136466, createdName=ooo0830, createdTime=Mon May 24 20:09:07 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-12-21 ms4000001060959647

    好文章，学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1186009, encodeId=c1ce1186009c2, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/tFIbqG99ULWomyW3q9TDNWhssrBa1C42kwt9ViaYyFDEZaPsW5uSkpdc5yQ7P9X63kiaRQzMr6durvzUyNNNULBw/132, createdBy=396a2268565, createdName=yumeng0126, createdTime=Wed Jan 19 14:03:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082310, encodeId=f988108231052, content=好文章，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf915716762, createdName=ms4000001060959647, createdTime=Tue Dec 21 06:55:17 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998739, encodeId=a7cc998e393d, content=学习，有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:04:49 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970353, encodeId=b3c89e035343, content=学习，好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOE7FCnhQj6vMstukoEoP7anFuTKzdMKnbTfCYicnCjiboPUiaSFo4oOsupAWuaibPWgSFribubP16FHA/132, createdBy=11935284296, createdName=visa, createdTime=Wed Jun 02 15:36:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968219, encodeId=4e30968219d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1bb2136466, createdName=ooo0830, createdTime=Mon May 24 20:09:07 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-07-12 1e22b426m70(暂无匿称)

    学习，有用！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1186009, encodeId=c1ce1186009c2, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/tFIbqG99ULWomyW3q9TDNWhssrBa1C42kwt9ViaYyFDEZaPsW5uSkpdc5yQ7P9X63kiaRQzMr6durvzUyNNNULBw/132, createdBy=396a2268565, createdName=yumeng0126, createdTime=Wed Jan 19 14:03:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082310, encodeId=f988108231052, content=好文章，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf915716762, createdName=ms4000001060959647, createdTime=Tue Dec 21 06:55:17 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998739, encodeId=a7cc998e393d, content=学习，有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:04:49 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970353, encodeId=b3c89e035343, content=学习，好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOE7FCnhQj6vMstukoEoP7anFuTKzdMKnbTfCYicnCjiboPUiaSFo4oOsupAWuaibPWgSFribubP16FHA/132, createdBy=11935284296, createdName=visa, createdTime=Wed Jun 02 15:36:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968219, encodeId=4e30968219d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1bb2136466, createdName=ooo0830, createdTime=Mon May 24 20:09:07 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-06-02 visa

    学习，好文章。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1186009, encodeId=c1ce1186009c2, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/tFIbqG99ULWomyW3q9TDNWhssrBa1C42kwt9ViaYyFDEZaPsW5uSkpdc5yQ7P9X63kiaRQzMr6durvzUyNNNULBw/132, createdBy=396a2268565, createdName=yumeng0126, createdTime=Wed Jan 19 14:03:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082310, encodeId=f988108231052, content=好文章，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf915716762, createdName=ms4000001060959647, createdTime=Tue Dec 21 06:55:17 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998739, encodeId=a7cc998e393d, content=学习，有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:04:49 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970353, encodeId=b3c89e035343, content=学习，好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOE7FCnhQj6vMstukoEoP7anFuTKzdMKnbTfCYicnCjiboPUiaSFo4oOsupAWuaibPWgSFribubP16FHA/132, createdBy=11935284296, createdName=visa, createdTime=Wed Jun 02 15:36:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968219, encodeId=4e30968219d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1bb2136466, createdName=ooo0830, createdTime=Mon May 24 20:09:07 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-05-24 ooo0830

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2019 ASCCP共识指南：宫颈癌筛查和癌前病变管理

美国阴道镜检查和宫颈病理学会(ASCCP,American Society for Colposcopy and Cervical Pathology) · 2020-04-01

宫颈癌微创手术的中国专家共识

中华医学会妇科肿瘤学分会 · 2019-11-01

2019专家建议：接受贝伐单抗治疗的卵巢癌和宫颈癌患者高血压的管理

国外肿瘤科相关专家小组（统称） · 2019-06-11

宫颈癌诊疗规范（2018年版）

中华人民共和国国家卫生健康委员会 · 2018-12-13

拓展阅读

2010 NACB医学实践指南：肝癌、膀胱癌、子宫颈癌、胃癌肿瘤标志物的应用

美国临床生化科学院(NACB,The National Academy of Clinical Biochemistry) · 2010-01-01

2010ESMO临床实践指南：宫颈癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2010 宫颈癌规范化诊治指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-11-16

2011SOGC 低资源地区宫颈癌的预防

加拿大妇产科医生协会(SOGC,Society of Obstetricians and Gynaecologists of Canada) · 2011-03-01

2011 ESUR指南：宫颈癌MRI分期

欧洲泌尿生殖放射学会(ESUR,European Society of Urogenital Radiology) · 2011-05-10

2011 子宫颈癌诊断指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01